BioSpace News Archive

Genetic Technologies Limited, a global leader in guidance-driven genomics-based tests in health, wellness and serious diseases releases its Quarterly business update for the quarter ended 31 December 2022.

Halia Therapeutics today announced that David J. Bearss , Ph.D., CEO of Halia Therapeutics, will be presenting at the BIO CEO & Investor Conference on Tuesday, February 7.

Medical iSight Corp (‘MiS’), developer of a next-generation 3D digital surgery platform, is pleased to announce a development partnership with NYU Langone Health’s Division of Neuroradiology.

Abcam plc, a global leader in the supply of life science research tools, provides the following preliminary trading update for the year ending 31 December 2022.

ClariMed, Inc., today announced the launch of the first MedTech services partner to take an integrated, human-centric approach to medical product development.

Aethlon Medical, Inc. today announced that it has entered into an agreement with NAMSA.

Vesigen Therapeutics, Inc. today announced the addition of Rakhshita Dhar, Senior Director of Venture Investments Health at Leaps by Bayer, to its Board of Directors.

Alto Neuroscience Inc. today announced a $25 million equity investment by new investor, Alpha Wave Ventures.

Summit Therapeutics Inc. (NASDAQ: SMMT) (“Summit” or the “Company”) today announced that the Company’s Board of Directors has set the record date for the Company’s previously announced rights offering, which will be available to all holders of record of the Company’s common stock, par value $0.01 (the “Common Stock”), as of the close of the market on February 6, 2023 (the “Record Date”).

Delcath Systems, Inc. (Nasdaq: DCTH), an interventional oncology company focused on the treatment of primary and metastatic cancers of the liver, will participate at the BTIG MedTech, Digital Health, Life Sciences, & Diagnostics Tools Conference in Snowbird, Utah on February 14 to 16.